Placeholder Banner

Politicking Biopharma Delays Cures

October 1, 2015
Forbes’ Matthew Herper ran a guest post from Robert Nelsen, cofounder and managing director of ARCH Venture Partners, which addresses the challenges our industry is currently facing amid the continued need for biomedical innovation.
Read it here.